$3.87
0.00%
Nasdaq, Mon, Jul 28 2025
ISIN
US44934S2068
Symbol
ICAD

Key metrics

Basic
Market capitalization
$106.3m
Enterprise Value
$86.3m
Net debt
positive
Cash
$20.0m
Shares outstanding
27.2m
Valuation (TTM | estimate)
P/E
- | -
P/S
5.4 | 5.2
EV/Sales
4.4 | 4.2
EV/FCF
negative
P/B
3.5
Financial Health
Equity Ratio
76.4%
Return on Equity
-19.6%
ROCE
-18.7%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$19.5m | $20.3m
EBITDA
$-5.7m | $-4.2m
EBIT
$-6.0m | $-5.9m
Net Income
$-5.2m | $-5.0m
Free Cash Flow
$-2.8m
Growth (TTM | estimate)
Revenue
18.4% | 3.6%
EBITDA
-15.8% | 27.8%
EBIT
-14.4% | 2.3%
Net Income
-128.4% | 11.2%
Free Cash Flow
49.8%
Margin (TTM | estimate)
Gross
85.6%
EBITDA
-29.3% | -20.8%
EBIT
-30.5%
Net
-26.8% | -24.6%
Free Cash Flow
-14.2%
More
EPS
$-0.2
FCF per Share
$-0.1
Short interest
1.1%
Employees
66
Rev per Employee
$300.0k
Show more

Is iCAD, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

iCAD, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a iCAD, Inc. forecast:

6x Buy
60%
4x Hold
40%

Analyst Opinions

10 Analysts have issued a iCAD, Inc. forecast:

Buy
60%
Hold
40%

Financial data from iCAD, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
20 20
18% 18%
100%
- Direct Costs 2.82 2.82
64% 64%
14%
17 17
13% 13%
86%
- Selling and Administrative Expenses 16 16
2% 2%
80%
- Research and Development Expense 6.58 6.58
50% 50%
34%
-5.72 -5.72
16% 16%
-29%
- Depreciation and Amortization 0.24 0.24
11% 11%
1%
EBIT (Operating Income) EBIT -5.96 -5.96
14% 14%
-31%
Net Profit -5.23 -5.23
128% 128%
-27%

In millions USD.

Don't miss a Thing! We will send you all news about iCAD, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

iCAD, Inc. Stock News

Neutral
Business Wire
2 months ago
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of iCAD, Inc. (NasdaqCM: ICAD) to RadNet, Inc. (NasdaqGM: RDNT). Under the terms of the proposed transaction, shareholders of iCAD will receive 0.0677 shares of RadNet for each share of iCAD that they own....
Neutral
GlobeNewsWire
3 months ago
NASHUA, N.H., May 13, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the three months ended March 31, 2025.
Neutral
Business Wire
4 months ago
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of iCAD, Inc. (NasdaqCM: ICAD) to RadNet, Inc. (NasdaqGM: RDNT). Under the terms of the proposed transaction, shareholders of iCAD will receive 0.0677 shares of RadNet for each share of iCAD that they own....
More iCAD, Inc. News

Company Profile

iCAD, Inc. is a medical technology company, which engages in the provision cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment include image analysis and workflow products. The Cancer Therapy segment consists radiation therapy products. The company was founded in 1984 and is headquartered in Nashua, NH.

Head office United States
CEO Dana Brown
Employees 66
Founded 1984
Website www.icadmed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today